Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of SPARC1104 in MS Spasticity
NCT01797185Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Apr 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of baclofen in spasticity (3 arms), sponsored by Sun Pharma. Primary endpoint: Adverse Events at 52 weeks. Started Apr 2013; status: completed.
02
Drugs
baclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01797185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797185.